UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

Vaccine, 2020-11, Vol.38 (47), p.7409-7413

2020

Volltextzugriff (PDF)

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002535

2021

Volltextzugriff (PDF)

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

Vaccine, 2019-06, Vol.37 (29), p.3770-3778

2019

Volltextzugriff (PDF)

Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries

AIDS (London), 2007-07, Vol.21 Suppl 4 (Suppl 4), p.S81-S87

Cohen, Gary M

2007

Volltextzugriff (PDF)

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge

Vaccine, 2010-09, Vol.28 (40), p.6627-6636

2010

Volltextzugriff (PDF)

Role of Public-Private Partnerships in Meeting Healthcare Challenges in Africa: A Perspective From the Private Sector

The Journal of infectious diseases, 2016-04, Vol.213 (suppl 2), p.S33-S33

Cohen, Gary

2016

Volltextzugriff (PDF)

Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes

Journal of Virology, 2006-06, Vol.80 (11), p.5283-5291

2006

Volltextzugriff (PDF)

Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs

Frontiers in immunology, 2016, Vol.7, p.640-640

2016

Volltextzugriff (PDF)

LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

Immunity (Cambridge, Mass.), 1998, Vol.8 (1), p.21-30

1998

Volltextzugriff (PDF)

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

Nature, 2004-03, Vol.428 (6979), p.182-185

2004

Volltextzugriff (PDF)

Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

Nature Medicine, 2008-02, Vol.14 (2), p.205-212

2008

Volltextzugriff (PDF)

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost

Vaccine, 2007-01, Vol.25 (7), p.1214-1224

2007

Volltextzugriff (PDF)

Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig

Vaccine, 2011-03, Vol.29 (11), p.2071-2078

2011

Volltextzugriff (PDF)

Antibody Responses to Vaccinia Membrane Proteins after Smallpox Vaccination

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.220-229

2007

Volltextzugriff (PDF)

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

Vaccine, 2008-02, Vol.26 (9), p.1195-1203

2008

Volltextzugriff (PDF)

Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus

Journal of Immunology, 2007-05, Vol.178 (10), p.6374-6386

2007

Volltextzugriff (PDF)

Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes

Vaccine, 2019-10, Vol.37 (43), p.6470-6477

2019

Volltextzugriff (PDF)

The three HveA receptor ligands, gD, LT-α and LIGHT bind to distinct sites on HveA

Molecular immunology, 2000-08, Vol.37 (11), p.665-673

2000

Volltextzugriff (PDF)

Localization of the gD-Binding Region of the Human Herpes Simplex Virus Receptor, HveA

Journal of Virology, 2001-01, Vol.75 (1), p.171-180

2001

Volltextzugriff (PDF)

Mechanism of complement inactivation by glycoprotein C of herpes simplex virus

The Journal of immunology (1950), 1997-02, Vol.158 (4), p.1763

1997

Volltextzugriff (PDF)

Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization

The Journal of infectious diseases, 1990-08, Vol.162 (2), p.331

1990

Volltextzugriff (PDF)

Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein

Journal of Virology, 1991-08, Vol.65 (8), p.4424-4431

1991

Volltextzugriff (PDF)

Herpes simplex virus glycoprotein C is a receptor for complement component iC3b

The Journal of infectious diseases, 1991-10, Vol.164 (4), p.750

1991

Volltextzugriff (PDF)

A comparative study of herpes simplex infections in renal transplant and leukemic patients

The Journal of infectious diseases, 1987-08, Vol.156 (2), p.280

1987

Volltextzugriff (PDF)

Functional T Cell Recognition of Synthetic Peptides Corresponding to Continuous Antibody Epitopes of Herpes Simplex Virus Type 1 Glycoprotein D

Immunobiology (1979), 1988-05, Vol.177 (2), p.134-148

1988

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(96)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(89)
Humans
(56)
Infectious Diseases
(39)
Female
(38)
Animals
(31)
Microbiology
(31)
Biological And Medical Sciences
(30)
Male
(26)
Virology
(22)
Adult
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
Hiv
(16)
Medical Sciences
(16)
Infections
(14)
Medicine, Research & Experimental
(14)
Mice
(14)
Research & Experimental Medicine
(14)
Middle Aged
(13)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge

Role of Public-Private Partnerships in Meeting Healthcare Challenges in Africa: A Perspective From the Private Sector

Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes

Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs

LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost

Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig

Antibody Responses to Vaccinia Membrane Proteins after Smallpox Vaccination

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus

Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes

The three HveA receptor ligands, gD, LT-α and LIGHT bind to distinct sites on HveA

Localization of the gD-Binding Region of the Human Herpes Simplex Virus Receptor, HveA

Mechanism of complement inactivation by glycoprotein C of herpes simplex virus

Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization

Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein

Herpes simplex virus glycoprotein C is a receptor for complement component iC3b

A comparative study of herpes simplex infections in renal transplant and leukemic patients

Functional T Cell Recognition of Synthetic Peptides Corresponding to Continuous Antibody Epitopes of Herpes Simplex Virus Type 1 Glycoprotein D

Aktive Filter

Suchergebnisse filtern